NCT06430047View on ClinicalTrials.gov

Efficacy and Safety of EsoDuo®

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

May 31, 2025

Conditions
Gastro Esophageal Reflux
Interventions
DRUG

EsoDuo® Tablet

QD, PO

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY